A Randomized, Open Label, Single Dose, 2X2 Cross-over Study to Compare Pharmacokinetics Between Rosuvastatin 10mg and Omega-3 1g Co-administration and HCP1007 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Omgea-3 fatty acid/rosuvastatin (Primary) ; Omega-3-acid ethyl esters; Rosuvastatin
- Indications Lipid metabolism disorders
- Focus Pharmacokinetics
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000435).
- 19 Mar 2012 New trial record